Tom Richardson

Tom Richardson serves as the Head of Medicinal Chemistry and has amassed over two decades of experience in the field of integrated drug discovery. His expertise is particularly noted in the development of novel T-Type calcium channel inhibitors, which are used for neurological and oncology indications. Richardson is a co-inventor on 15 patents and has contributed as a co-author to several publications in peer-reviewed journals. His extensive knowledge and experience have been pivotal in crafting new intellectual property to secure patent space in the competitive field of medicinal chemistry. He holds a PhD in Organic Chemistry from The Ohio State University, further underlining his deep understanding and capability in his field.